[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 21, 2017 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Provinc]
[China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017 3Q17 Added 19,712 New Subscribers 3Q17 Revenue Up 18.6% YOY to RMB200.9 Million ($28.9 Million) 3Q17 Operating Income Reached RMB101.7 Million ($14.6 Million) Conference Call to be Held ]
[Qunar Announces Shareholder Approval of Merger Agreement Completion of the Merger is subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement. The Company will work with the other parties to the Merger Agreement to satisfy all other conditions precedent to the Merger]
[QuickLinks -- Click here to rapidly navigate through this document Management's Discussion and Analysis of Financial Condition and Results of Operations for the Six Months Ended June 30, 2016 Revenues Revenue composition and sources of revenue growth. In the first six months of 2016, we generated to]
[PROSPECTUS SUPPLEMENT Ctrip.com International, Ltd.]
[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 21, 2017 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Provinc]
[QuickLinks -- Click here to rapidly navigate through this document Management's Discussion and Analysis of Financial Condition and Results of Operations for the Six Months Ended June 30, 2016 Revenues Revenue composition and sources of revenue growth. In the first six months of 2016, we generated to]
